Gottlieb releases FDA's plan to combat antibiotic resistance, calls for funding

FDA Commissioner Scott Gottlieb reiterated the call for new funding mechanisms to combat antimicrobial resistance during remarks made at a Pew Charitable Trusts meeting Friday. Gottlieb also revealed FDA's 2019 strategic plan to address AMR, noting it builds on the agency's past efforts and will bring together the agency's centers.

FDA will address four key areas, Gottlieb said, aimed at facilitating product development; promoting antimicrobial stewardship to preserve the effectiveness of available treatments and slow antimicrobial resistance; developing tools for surveillance of antimicrobial use and resistance; and researching alternative treatment approaches such as bacteriophages and fecal transplants...